They fully recovered. Just like he said. Two went
Post# of 148183
Quote:
It has been shown that in patients with severe COVID-19 treatment with leronlimab
reduces elevated plasma IL-6 and chemokine ligand 5 (CCL5), and normalized CD4/CD8 ratios.
We administered leronlimab to 4 critically ill COVID-19 patients in intensive care. All 4 of these
patients improved clinically as measured by vasopressor support, and discontinuation of
hemodialysis and mechanical ventilation. Following administration of leronlimab there was a
statistically significant decrease in IL-6 observed in patient A (p=0.034) from day 0 to 7 and
patient D (p=0.027) from day 0 to 14. This corresponds to restoration of the immune function
as measured by CD4+/CD8+ T cell ratio. Although two of the patients went on to survive the
other two subsequently died of surgical complications after an initial recovery from SARS-CoV-2
infection.